Products with Antioxidants bioactivity
| Cat.No. | Product Name |
|---|---|
| BCN6637 | 11-O-Galloylbergenin |
| 1. 11-O-Galloylbergenin shows significant analgesic activity at doses of 20 and 40 mg/kg against formalin test in rats, and it exhibits significant anti-inflammatory activity in carrageenan-induced paw edema model at doses of 10, 20 and 30 mg/kg. 2. 11-O-Galloylbergenin shows good antioxidant and antiplasmodial activities, the EC50 values are 7.45±0.2 ug/mL and 5.39±0.28 ug/mL in DPPH antioxidant assay and reducing power assay respectively, while IC50 value for antiplasmodial assay is less than 2.5 uM. 3. 11-O-Galloylbergenin shows significant urease inhibitory potential with IC50 value of 38.6±1.5 uM. | |
| BCN6638 | Ligucyperonol |
| 1. Ligucyperonol exhibits significant activities on protecting muscle cells from mild to moderate oxidative stress. | |
| BCN6643 | 4-O-Galloylbergenin |
| 1. 4-O-Galloylbergenin shows significant 2,2-diphenyl-1-picrylhydrazyl (DPPH) free-radical scavenging activity with EC₅₀ 7.8 uM, it shows more antioxidant activity than the positive control vitamin C (EC₅₀ = 28.3 uM). | |
| BCN6660 | Taxoquinone |
| 1. Taxoquinone shows significant and concentration-dependent antioxidant and free radical scavenging activities of DPPH, nitric oxide, superoxide and hydroxyl free radicals by 78.83%, 72.42%, 72.99% and 85.04%, as compared to standard compounds ascorbic acid (81.69%, 74.62%, 73% and 73.79%). 2. Taxoquinone at the concentration range of 100-3,000 ug/mL and 200-1,000 ug/mL shows potent efficacy on inhibiting α-glucosidase and tyrosinase enzymes by 9.24-51.32% and 11.14-52.32%, respectively; suggests that taxoquinone could as a novel candidate in food and medicine industry as a natural alternative medicine to prevent diabetes mellitus type-2 related disorders and as a depigmentation agent. 3. Taxoquinone (100 ug/disc) displays potential anticandidal effect against Candia albicans. 4. Taxoquinone has strong antibacterial effect, it could be used as a promising antibacterial agent in food industry to inhibit the growth of certain important foodborne pathogens. | |
| BCN6662 | Licorisoflavan A |
| 1. Licorisoflavan A shows weak scavenging activity against superoxide anion radical. 2. Licorisoflavan A has bactericidal effects on S. mutans UA159 at the concentration of ≥4 g/ml, it can be useful in developing oral hygiene products, such as gargling solutions and dentifrices for preventing dental caries. 3. Licorisoflavan A and licoricidin have potential for the development of novel host-modulating strategies for the treatment of cytokine and/or MMP-mediated disorders such as periodontitis. | |
